Nitrosigine 750 mg By Swanson Overview & Drug Interactions
Check For Interactions With Nitrosigine 750 mg
Supplement: Nitrosigine 750 mg by Swanson
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Potassium
Ingredient Group | Potassium |
---|---|
Category | mineral |
- Nitrosigine
Arginine Silicate Inositol
Inositol is a type of carbohydrate (sugar alcohol) that is found in a variety of foods, including fruits, nuts, and grains. It is also known as vitamin B8 but is not considered 'essential' as it can be synthesized in the human body. Inositol is involved in a number of important physiological processes, including the metabolism of fats, the regulation of insulin, and the transmission of nerve impulses. Inositol is a popular dietary supplement and is believed to have a number of potential health benefits. It is thought to have a role in the treatment of certain mental health conditions, is believed to have a positive effect on cholesterol levels and may be helpful in the prevention or management of heart disease. In addition, inositol may have anti-inflammatory effects and may be helpful in the treatment of certain skin conditions.
See More Information Regarding InositolIngredient Group | Arginine silicate inositol |
---|---|
Category | non-nutrient/non-botanical |
Drugs that interact with Nitrosigine 750 mg by Swanson
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
---|---|
Minimum serving Sizes: |
1 Tablet(s)
|
Maximum serving Sizes: |
1 Tablet(s)
|
UPC/BARCODE | 087614029030 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Potassium |
30 mg
|
Potassium |
1%
|
Arginine Silicate Inositol |
750 mg
|
Arginine silicate inositol |
--
|
Other Ingredients: |
Dicalcium Phosphate
Stearic Acid
Microcrystalline Cellulose
Forms
Hydroxypropyl Cellulose
Magnesium Stearate
Aqueous Film-Coating
Forms
Croscarmellose Sodium
Silica
|
---|
Label Statments:
General Statements |
- Promotes nitric oxide production
Patented complex that supports heart and circulatory health
Maintains energy metabolism
Science-Backed Quality Since 1969
- Cardiovascular Support
|
---|---|
Suggested/Recommended/Usage/Directions |
- Suggested use: As a dietary supplement, take one tablet one to two times per day with water.
|
Brand IP Statement(s) |
- Nitrosigine is a registered trademark of Nutrition 21, LLC., and is protected by U.S. patents: #5,707,970; #6,156,735; #6,344,444; and #7,576,132.
|
Precautions |
- Warning: For adults only.
- Consult your physician before using this or any product if you are pregnant or nursing, taking medication or have a medical condition.
- Keep out of reach of children.
- Do not use if seal is broken.
|
Storage |
- Store in a cool, dry place.
|
FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
Formula |
- Arginine Silicate Inositol
|
FDA Statement of Identity |
- Dietary Supplement
|
General |
- SWU903 Rev 0 05 05 18
|
Brand Information
See all products by this brand
Distributed by | |
---|---|
Name | Swanson Health Products |
City | Fargo |
State | ND |
Country | USA |
ZipCode | 58104 |
Phone Number | 1-800-437-4148 |
Web Address | swanson.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.